Kleinman Ronald E, Baldassano Robert N, Caplan Arlene, Griffiths Anne M, Heyman Melvin B, Issenman Robert M, Lake Alan M, Motil K J, Seidman E, Udall J N
NASPGHAN, Flourtown, PA, USA.
J Pediatr Gastroenterol Nutr. 2004 Jul;39(1):15-27. doi: 10.1097/00005176-200407000-00005.
Impairment of growth and malnutrition are significant complications of inflammatory bowel disease (IBD) in pediatric patients. Since this topic was last reviewed in these pages (), a number of studies have further explored the epidemiology and pathogenesis of these nutritional complications of IBD in an effort to provide more effective interventions to prevent the long-term consequences of chronic nutrient deficiencies in childhood. In addition, during the past 15 years, the use of selected nutrients and microorganisms (probiotics) as primary or adjunctive therapy for the treatment of IBD has become an emerging area of great interest. The following is a Clinical Report from the Nutrition and Inflammatory Bowel Disease Committees of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
生长发育受损和营养不良是儿科炎症性肠病(IBD)的重要并发症。自从本领域上次在本刊进行综述以来,已有多项研究进一步探究了IBD这些营养并发症的流行病学和发病机制,旨在提供更有效的干预措施,以预防儿童期慢性营养缺乏的长期后果。此外,在过去15年中,使用特定营养素和微生物(益生菌)作为IBD的主要或辅助治疗方法已成为一个备受关注的新兴领域。以下是北美儿科胃肠病学、肝病学和营养学会营养与炎症性肠病委员会的一份临床报告。